2019
DOI: 10.3389/fchem.2019.00475
|View full text |Cite
|
Sign up to set email alerts
|

Multicomponent Reactions Upon the Known Drug Trimethoprim as a Source of Novel Antimicrobial Agents

Abstract: Novel antibiotic compounds have been prepared through a selective multicomponent reaction upon the known drug Trimethoprim. The Groebke-Blackburn-Bienaymé reaction involving this α-aminoazine, with a range of aldehydes and isocyanides afforded the desired adducts in one-step. The analogs display meaningful structural features of the initial drug together with relevant modifications at several points, keeping antibiotic potency and showing satisfactory antimicrobial profile (good activity levels and reduced gro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 31 publications
0
22
0
Order By: Relevance
“…One of our reviews presents an extensive range of research literature on the first and most recent achievements in TMP analogs as DHFR inhibitors and underlines new directions in developing and modeling DHFR inhibitors [33]. Currently, Pedrola et al [34] showed group of TMP analogs display meaningful structural features of the initial drug together with relevant modifications at several points, keeping antibiotic potency and showing satisfactory antimicrobial profile (good activity levels and reduced growth rates), especially against methicillin-resistant Staphylococcus aureus (Figure 1). The new products may open new possibilities to fight bacterial infections.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…One of our reviews presents an extensive range of research literature on the first and most recent achievements in TMP analogs as DHFR inhibitors and underlines new directions in developing and modeling DHFR inhibitors [33]. Currently, Pedrola et al [34] showed group of TMP analogs display meaningful structural features of the initial drug together with relevant modifications at several points, keeping antibiotic potency and showing satisfactory antimicrobial profile (good activity levels and reduced growth rates), especially against methicillin-resistant Staphylococcus aureus (Figure 1). The new products may open new possibilities to fight bacterial infections.…”
Section: Introductionmentioning
confidence: 99%
“…Singh et al [35] modified the antibacterial agent TMP to compounds A and B ( Figure 1) with promising anticancer applications. These two compounds had significant tumor growth inhibitory activities over 60 human tumor cell lines and exhibited appreciable interactions with DHFR [34]. Algul et al [36] have developed a new nonclassical series of propargyl-linked DHFR inhibitors.…”
Section: Introductionmentioning
confidence: 99%
“…[29] The antibiotic trimethoprim suitably reacted likewise to give adduct 7 h (31 %). [30] Interestingly, 2,4-diaminopyrimidine adducts react smoothly in air, not requiring other oxidants, probably due to their higher electron density.…”
Section: Methodsmentioning
confidence: 99%
“…2,4‐Diaminopyrimidine yielded the adducts 7 f (26 %) and 7 g (11 %) in a regioselective manner, following the protocol developed by the group [29] . The antibiotic trimethoprim suitably reacted likewise to give adduct 7 h (31 %) [30] . Interestingly, 2,4‐diaminopyrimidine adducts react smoothly in air, not requiring other oxidants, probably due to their higher electron density.…”
Section: Figurementioning
confidence: 99%